Drugs / High-dose Interferon alfa-2b
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01943422 | Oct 2013 → Nov 2016 | melanoma | John Kirkwood | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | High-dose Interferon alfa-2b | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01943422 ↗ |
| Route | Intravenous | “IFNα-2b will be administered intravenously” NCT01943422 ↗ |